You are here

  • Home
  • Archive
  • Volume 30, Issue e1
  • Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19

Article metrics

Article menu

Download PDFPDF

Short report
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 202133032871
Jun 202123623711
Jul 2021989816
Aug 2021515212
Sep 202127266
Oct 2021575724
Nov 2021989927
Dec 20211421428
Jan 202219419717
Feb 202211311222
Mar 202214514811
Apr 202217417315
May 202217317542
Jun 202212312426
Jul 202216416413
Aug 202214814810
Sep 202216816712
Oct 202211711713
Nov 202212612613
Dec 202216716724
Jan 202314214118
Feb 20231161166
Mar 202313113116
Apr 202310510527
May 2023888623
Jun 2023828418
Jul 202310410521
Aug 20231881867
Sep 20231281283
Oct 202388886
Nov 202387876
Dec 202389889
Jan 2024323111
Feb 2024545413
Mar 2024383753
Total43234324630